<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03872739</url>
  </required_header>
  <id_info>
    <org_study_id>201704020124</org_study_id>
    <nct_id>NCT03872739</nct_id>
  </id_info>
  <brief_title>To Compare Intravenous and Oral Hydration of the Prevention for CIN in Elderly Patients Undergoing Intravenous CECT</brief_title>
  <acronym>CINOECT</acronym>
  <official_title>To Compare Intravenous and Oral Hydration of the Prevention for Contrast-induced Nephropathy in Elderly Patients Undergoing Intravenous Contrast-enhanced Computed Tomographyï¼š A Multi-center Randomized Control Trail</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yu Danqing</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangdong Academy of Medical Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To Compare Intravenous and Oral Hydration of the Prevention for Contrast-induced Nephropathy&#xD;
      in Elderly Patients Undergoing Intravenous Contrast-enhanced Computed Tomography.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The prospective multicenter randomized controlled clinical research discusses the comparison&#xD;
      of oral and intravenous hydration for prevention of contrast-induced nephropathy in elderly&#xD;
      patients with enhanced computed tomography, establishing a simple hydration proposal.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">October 8, 2016</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CIN</measure>
    <time_frame>72hours</time_frame>
    <description>Compared with before examination, the increase of serum creatinine conforms to the diagnostic criteria of contrast induced nephropathy.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1368</enrollment>
  <condition>CIN</condition>
  <arm_group>
    <arm_group_label>distilled water</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral distilled water at the rate of 3 mL/kg/h rate during undergoing enhanced computed tomography examination before 1-2 and after 4-6 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>intravenous saline hydration at the rate of 1 mL/kg/h rate during undergoing enhanced computed tomography examination before and after 12 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>enhanced computed tomography</intervention_name>
    <description>undergoing enhanced computed tomography</description>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_label>distilled water</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age&gt;21&#xD;
&#xD;
          -  informed consent&#xD;
&#xD;
          -  Undergoing Intravenous Contrast-enhanced Computed Tomography&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  CT enhancement was not performed;&#xD;
&#xD;
          -  Dialysis treatment of patients with end-stage renal failure or heart, kidney&#xD;
             transplantation;&#xD;
&#xD;
          -  Exposure to radioactive contrast medium within 48 hours prior to or within 72 hours of&#xD;
             examination;&#xD;
&#xD;
          -  Acute decompensated heart failure;&#xD;
&#xD;
          -  Allergic to radioactive contrast agent;&#xD;
&#xD;
          -  Be subjected to life - threatening trauma;&#xD;
&#xD;
          -  Severe infection;&#xD;
&#xD;
          -  Surgery was performed within 2 days of CT examination.&#xD;
&#xD;
          -  Combined with multiple myeloma, urinary obstruction, aortic dissection&#xD;
&#xD;
          -  Can cause acute kidney injury disease;&#xD;
&#xD;
          -  Use of aminoglycosides and other nephrotoxic drugs 2 weeks before.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Danqing Yu, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guangdong Cardiovascular Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Danqing Yu, Doctor</last_name>
    <phone>13631349257</phone>
    <email>gdydq100@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Guangdong provincial people's hospital</name>
      <address>
        <city>Guanzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>huang jieleng, doctor</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>February 27, 2019</study_first_submitted>
  <study_first_submitted_qc>March 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 13, 2019</study_first_posted>
  <last_update_submitted>March 10, 2019</last_update_submitted>
  <last_update_submitted_qc>March 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Guangdong Academy of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Yu Danqing</investigator_full_name>
    <investigator_title>Director,Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>CIN</keyword>
  <keyword>Hydration</keyword>
  <keyword>enhanced computed tomography</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

